nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—Hydrochlorothiazide—nephrolithiasis	0.449	1	CrCtD
Diclofenamide—Quinethazone—Hydrochlorothiazide—nephrolithiasis	0.0721	0.271	CrCrCtD
Diclofenamide—Methyclothiazide—Hydrochlorothiazide—nephrolithiasis	0.0663	0.249	CrCrCtD
Diclofenamide—Trichlormethiazide—Hydrochlorothiazide—nephrolithiasis	0.0663	0.249	CrCrCtD
Diclofenamide—Chlorothiazide—Hydrochlorothiazide—nephrolithiasis	0.0614	0.231	CrCrCtD
Diclofenamide—CA5B—Hydrochlorothiazide—nephrolithiasis	0.0535	0.201	CbGbCtD
Diclofenamide—CA12—Hydrochlorothiazide—nephrolithiasis	0.0459	0.173	CbGbCtD
Diclofenamide—CA9—Hydrochlorothiazide—nephrolithiasis	0.0459	0.173	CbGbCtD
Diclofenamide—CA1—Hydrochlorothiazide—nephrolithiasis	0.043	0.162	CbGbCtD
Diclofenamide—CA4—Hydrochlorothiazide—nephrolithiasis	0.0404	0.152	CbGbCtD
Diclofenamide—CA2—Hydrochlorothiazide—nephrolithiasis	0.0371	0.14	CbGbCtD
Diclofenamide—CA2—collecting duct of renal tubule—nephrolithiasis	0.00206	0.314	CbGeAlD
Diclofenamide—CA4—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.0015	0.221	CbGpPWpGaD
Diclofenamide—CA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00144	0.212	CbGpPWpGaD
Diclofenamide—CA1—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00138	0.203	CbGpPWpGaD
Diclofenamide—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.000961	0.169	CcSEcCtD
Diclofenamide—CYP2C9—urine—nephrolithiasis	0.000622	0.0947	CbGeAlD
Diclofenamide—CA7—renal system—nephrolithiasis	0.00054	0.0821	CbGeAlD
Diclofenamide—CA7—kidney—nephrolithiasis	0.000522	0.0794	CbGeAlD
Diclofenamide—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.000433	0.076	CcSEcCtD
Diclofenamide—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.000409	0.0718	CcSEcCtD
Diclofenamide—CA12—renal system—nephrolithiasis	0.000351	0.0534	CbGeAlD
Diclofenamide—CA12—kidney—nephrolithiasis	0.000339	0.0516	CbGeAlD
Diclofenamide—CA1—renal system—nephrolithiasis	0.000278	0.0423	CbGeAlD
Diclofenamide—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.000274	0.0481	CcSEcCtD
Diclofenamide—CA1—kidney—nephrolithiasis	0.000269	0.0409	CbGeAlD
Diclofenamide—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.000265	0.0466	CcSEcCtD
Diclofenamide—CA4—nephron tubule—nephrolithiasis	0.000239	0.0363	CbGeAlD
Diclofenamide—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000233	0.0408	CcSEcCtD
Diclofenamide—CA4—renal system—nephrolithiasis	0.000217	0.033	CbGeAlD
Diclofenamide—CA4—kidney—nephrolithiasis	0.00021	0.0319	CbGeAlD
Diclofenamide—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000209	0.0368	CcSEcCtD
Diclofenamide—CA4—cortex of kidney—nephrolithiasis	0.000204	0.0311	CbGeAlD
Diclofenamide—CA2—nephron tubule—nephrolithiasis	0.000198	0.0301	CbGeAlD
Diclofenamide—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000188	0.033	CcSEcCtD
Diclofenamide—CA2—renal system—nephrolithiasis	0.00018	0.0274	CbGeAlD
Diclofenamide—CA2—kidney—nephrolithiasis	0.000174	0.0265	CbGeAlD
Diclofenamide—Tension—Hydrochlorothiazide—nephrolithiasis	0.000172	0.0302	CcSEcCtD
Diclofenamide—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00017	0.0299	CcSEcCtD
Diclofenamide—CA2—cortex of kidney—nephrolithiasis	0.000169	0.0258	CbGeAlD
Diclofenamide—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000164	0.0289	CcSEcCtD
Diclofenamide—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000157	0.0276	CcSEcCtD
Diclofenamide—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000144	0.0254	CcSEcCtD
Diclofenamide—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00014	0.0246	CcSEcCtD
Diclofenamide—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000136	0.024	CcSEcCtD
Diclofenamide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000129	0.0226	CcSEcCtD
Diclofenamide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000127	0.0224	CcSEcCtD
Diclofenamide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000126	0.0221	CcSEcCtD
Diclofenamide—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000124	0.0219	CcSEcCtD
Diclofenamide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000123	0.0217	CcSEcCtD
Diclofenamide—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000122	0.0215	CcSEcCtD
Diclofenamide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000118	0.0207	CcSEcCtD
Diclofenamide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000113	0.0199	CcSEcCtD
Diclofenamide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000103	0.018	CcSEcCtD
Diclofenamide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000101	0.0178	CcSEcCtD
Diclofenamide—Dizziness—Hydrochlorothiazide—nephrolithiasis	9.47e-05	0.0166	CcSEcCtD
Diclofenamide—Vomiting—Hydrochlorothiazide—nephrolithiasis	9.1e-05	0.016	CcSEcCtD
Diclofenamide—Rash—Hydrochlorothiazide—nephrolithiasis	9.03e-05	0.0159	CcSEcCtD
Diclofenamide—Headache—Hydrochlorothiazide—nephrolithiasis	8.97e-05	0.0158	CcSEcCtD
Diclofenamide—Nausea—Hydrochlorothiazide—nephrolithiasis	8.5e-05	0.0149	CcSEcCtD
Diclofenamide—CA14—Metabolism—GRHPR—nephrolithiasis	6.67e-05	0.00982	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GRHPR—nephrolithiasis	6.5e-05	0.00957	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GRHPR—nephrolithiasis	6.5e-05	0.00957	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GRHPR—nephrolithiasis	6.07e-05	0.00894	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GRHPR—nephrolithiasis	6.07e-05	0.00894	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—AGXT—nephrolithiasis	5.95e-05	0.00875	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—AGXT—nephrolithiasis	5.79e-05	0.00853	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—AGXT—nephrolithiasis	5.79e-05	0.00853	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GRHPR—nephrolithiasis	5.62e-05	0.00828	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—AGXT—nephrolithiasis	5.41e-05	0.00796	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—AGXT—nephrolithiasis	5.41e-05	0.00796	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—APRT—nephrolithiasis	5.06e-05	0.00744	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—SLC26A1—nephrolithiasis	5.06e-05	0.00744	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AGXT—nephrolithiasis	5.01e-05	0.00738	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—SLC26A1—nephrolithiasis	4.93e-05	0.00725	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—SLC26A1—nephrolithiasis	4.93e-05	0.00725	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—APRT—nephrolithiasis	4.93e-05	0.00725	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—APRT—nephrolithiasis	4.93e-05	0.00725	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—SLC26A1—nephrolithiasis	4.6e-05	0.00677	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—SLC26A1—nephrolithiasis	4.6e-05	0.00677	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—APRT—nephrolithiasis	4.6e-05	0.00677	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—APRT—nephrolithiasis	4.6e-05	0.00677	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GRHPR—nephrolithiasis	4.48e-05	0.0066	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GRHPR—nephrolithiasis	4.3e-05	0.00633	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—APRT—nephrolithiasis	4.26e-05	0.00627	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—SLC26A1—nephrolithiasis	4.26e-05	0.00627	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GRHPR—nephrolithiasis	4.12e-05	0.00607	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	4.1e-05	0.00603	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AGXT—nephrolithiasis	4e-05	0.00588	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AGXT—nephrolithiasis	3.83e-05	0.00564	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AGXT—nephrolithiasis	3.67e-05	0.00541	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GRHPR—nephrolithiasis	3.62e-05	0.00533	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—AQP1—nephrolithiasis	3.6e-05	0.0053	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—AQP1—nephrolithiasis	3.51e-05	0.00517	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—AQP1—nephrolithiasis	3.51e-05	0.00517	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—APRT—nephrolithiasis	3.4e-05	0.005	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—SLC26A1—nephrolithiasis	3.4e-05	0.005	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—AQP1—nephrolithiasis	3.28e-05	0.00483	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—AQP1—nephrolithiasis	3.28e-05	0.00483	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CHRM3—nephrolithiasis	3.26e-05	0.0048	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—SLC26A1—nephrolithiasis	3.26e-05	0.0048	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—APRT—nephrolithiasis	3.26e-05	0.0048	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AGXT—nephrolithiasis	3.23e-05	0.00475	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CHRM3—nephrolithiasis	3.17e-05	0.00467	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CHRM3—nephrolithiasis	3.17e-05	0.00467	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—APRT—nephrolithiasis	3.12e-05	0.0046	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—SLC26A1—nephrolithiasis	3.12e-05	0.0046	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—AQP1—nephrolithiasis	3.04e-05	0.00447	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CHRM3—nephrolithiasis	2.96e-05	0.00436	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CHRM3—nephrolithiasis	2.96e-05	0.00436	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—SLC26A1—nephrolithiasis	2.75e-05	0.00404	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—APRT—nephrolithiasis	2.75e-05	0.00404	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CHRM3—nephrolithiasis	2.75e-05	0.00404	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—AQP1—nephrolithiasis	2.42e-05	0.00357	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—AQP1—nephrolithiasis	2.32e-05	0.00342	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—AQP1—nephrolithiasis	2.23e-05	0.00328	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CHRM3—nephrolithiasis	2.19e-05	0.00322	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CHRM3—nephrolithiasis	2.1e-05	0.00309	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CHRM3—nephrolithiasis	2.01e-05	0.00296	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—AQP1—nephrolithiasis	1.96e-05	0.00288	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CHRM3—nephrolithiasis	1.77e-05	0.00261	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GRHPR—nephrolithiasis	9.25e-06	0.00136	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AGXT—nephrolithiasis	8.24e-06	0.00121	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APRT—nephrolithiasis	7.01e-06	0.00103	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	7.01e-06	0.00103	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—AQP1—nephrolithiasis	4.99e-06	0.000735	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CHRM3—nephrolithiasis	4.52e-06	0.000665	CbGpPWpGaD
